Abstract
Obesity is an emerging epidemic in Canada that poses a threat to public health. Pharmaceutical weight management is an option for managing excess weight. In this review, we briefly discuss the pathophysiology of obesity and present the current pharmacotherapy for its treatment, focusing on orlistat, naltrexone/bupropion, liraglutide, and semaglutide. In addition, we briefly discuss upcoming pharmacotherapies for the management of obesity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
